{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:33:20Z","timestamp":1785890000770,"version":"3.56.0"},"reference-count":87,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T00:00:00Z","timestamp":1430092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0117125","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T18:09:05Z","timestamp":1430158145000},"page":"e0117125","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV\/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia"],"prefix":"10.1371","volume":"10","author":[{"given":"Rudolph L.","family":"Gleason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Caulk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Seifu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brani","family":"Vidakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Getenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew","family":"Assefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wondwossen","family":"Amogne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"A Carr","year":"1999","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-200311210-00010","article-title":"Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men","volume":"17","author":"M Mary-Krause","year":"2003","journal-title":"AIDS"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"N Friis-Moller","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00002030-200404300-00010","article-title":"Colour-Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy: a comparative study","volume":"18","author":"P Maggi","year":"2004","journal-title":"AIDS"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1177\/135965350501000808","article-title":"Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy","volume":"10","author":"K Sevastianova","year":"2005","journal-title":"Antivir Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/597475","article-title":"Increase in carotid artery intima-media thickness and arterial stiffness but improvement in several markers of endothelial function after initiation of antiretroviral therapy","volume":"199","author":"M van Vonderen","year":"2009","journal-title":"Journal of Infectious Diseases"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.CIR.0000124480.32233.8A","article-title":"Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection","volume":"109","author":"P Hsue","year":"2004","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.CIR.104.3.257","article-title":"Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction","volume":"104","author":"J Stein","year":"2001","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ahj.2005.06.005","article-title":"Indinavir impairs endothelial function in healthy HIV-negative men","volume":"150","author":"S Shankar","year":"2005","journal-title":"American Heart Journal"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/381783","article-title":"Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?","volume":"189","author":"E Fontas","year":"2004","journal-title":"Journal of Infectious Diseases"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/QAD.0b013e32832e7140","article-title":"Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients","volume":"23","author":"PY Hsue","year":"2009","journal-title":"AIDS"},{"key":"ref12","unstructured":"UNAIDS (2012) Report on the Global AIDS Epidemic."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2005.09.073","article-title":"Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients","volume":"47","author":"JP van Wijk","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1210\/jc.2006-1140","article-title":"Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome","volume":"91","author":"S Johnsen","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.CIR.104.3.257","article-title":"Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction","volume":"104","author":"JH Stein","year":"2001","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ahj.2005.06.005","article-title":"Indinavir impairs endothelial function in healthy HIV-negative men","volume":"150","author":"SS Shankar","year":"2005","journal-title":"American Heart Journal"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jac\/dkl190","article-title":"Endothelial function in HIV-infected patients with low or mild cardiovascular risk","volume":"58","author":"JJ Blanco","year":"2006","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2005.09.025","article-title":"Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis","volume":"185","author":"SD Fisher","year":"2006","journal-title":"Atherosclerosis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients\u2014association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"N Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"SW Worm","year":"2010","journal-title":"Journal of Infectious Diseases"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/QAD.0b013e32811ebf79","article-title":"Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults","volume":"21","author":"JS Currier","year":"2007","journal-title":"AIDS"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/01.aids.0000171406.53737.f9","article-title":"Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure","volume":"19","author":"JS Currier","year":"2005","journal-title":"AIDS"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1086\/503807","article-title":"Lopinavir-ritonavir: effects on endothelial cell function in healthy subjects","volume":"193","author":"JR Grubb","year":"2006","journal-title":"Journal of Infectious Diseases"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/qjmed\/hcg145","article-title":"Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?","volume":"96","author":"D Nolan","year":"2003","journal-title":"QJM"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1086\/503261","article-title":"Endothelial function in HIV-infected persons","volume":"42","author":"A Solages","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/oxfordjournals.aje.a117315","article-title":"Arterial stiffness: a new cardiovascular risk factor?","volume":"140","author":"D Arnet","year":"1994","journal-title":"American Journal of Epidemiology"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, et al. (2011) T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis.","DOI":"10.1016\/j.atherosclerosis.2011.03.011"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/STROKEAHA.110.583856","article-title":"Association between human immunodeficiency virus infection and stiffness of the common carotid artery","volume":"41","author":"EC Seaberg","year":"2010","journal-title":"Stroke"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Hansen L, Parker I, Roberts LM, Sutliff R, Platt M, et al. (2013) Azidothymidine (AZT) leads to arterial stiffening and intima-media thickening in mice. Journal of Biomechanics In Press.","DOI":"10.1016\/j.jbiomech.2013.03.021"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/QAI.0b013e31819367cd","article-title":"Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophy","volume":"50","author":"M van Vonderen","year":"2009","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.109.864801","article-title":"Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis","volume":"120","author":"J Yeboah","year":"2009","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.atherosclerosis.2008.10.012","article-title":"Human immunodeficiency virus per se exerts atherogenic effects","volume":"204","author":"U Oliviero","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2008.04.049","article-title":"Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s","volume":"52","author":"F Torriani","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e45716","DOI":"10.1371\/journal.pone.0045716","article-title":"Worsening endothelial function with efavirenz compared to protease inhibitors: a 12-month prospective study","volume":"7","author":"SK Gupta","year":"2012","journal-title":"PloS one"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3851\/IMP1491","article-title":"Endothelial function is impaired in HIV-infected patients with lipodystrophy","volume":"15","author":"M Masi\u00e1","year":"2010","journal-title":"Antiviral therapy"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00126334-200304150-00004","article-title":"Brief report: carotid intima-media thickness in heavily pretreated HIV-infected patients","volume":"32","author":"G Chironi","year":"2003","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1468-1293.2005.00324.x","article-title":"Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients","volume":"6","author":"P Mercie","year":"2005","journal-title":"HIV Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.atherosclerosis.2006.12.022","article-title":"Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis","volume":"196","author":"M Lorenz","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/QAD.0b013e32832b514b","article-title":"Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis","volume":"23","author":"P Hsue","year":"2009","journal-title":"AIDS"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.atherosclerosis.2010.11.013","article-title":"Markers of atherosclerosis and inflammation and mortality in patients with HIV infection","volume":"214","author":"A Mangili","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/infdis\/jiq071","article-title":"T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women","volume":"203","author":"RC Kaplan","year":"2011","journal-title":"The Journal of infectious diseases"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Longenecker C, Funderburg N, Jiang Y, Debanne S, Storer N, et al. (2013) Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals. HIV Med.","DOI":"10.1111\/hiv.12013"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.atherosclerosis.2010.04.008","article-title":"Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children","volume":"211","author":"AC Ross","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3851\/IMP1682","article-title":"Framingham risk score and early markers of atherosclerosis in a cohort of adults infected with HIV","volume":"16","author":"EL Falcone","year":"2011","journal-title":"Antiviral therapy"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/JIM.0b013e3181788d15","article-title":"The role of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction","volume":"56","author":"ER Kline","year":"2008","journal-title":"J Investig Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jbiomech.2013.03.021","article-title":"Azidothymidine (AZT) leads to arterial stiffening and intima-media thickening in mice","volume":"46","author":"L Hansen","year":"2013","journal-title":"J Biomech"},{"key":"ref47","first-page":"H2363","article-title":"Nucleoside reverse transcriptase inhibitors impair endothelium-dependent relaxation by increasing superoxide","volume":"283","author":"R Sutliff","year":"2002","journal-title":"American Journal of Physiology: Heart and Circulatory Physiology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/QAD.0b013e328347fa16","article-title":"Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons","volume":"25","author":"AI Choi","year":"2011","journal-title":"AIDS"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1468-1293.2009.00763.x","article-title":"Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir","volume":"11","author":"JD Kowalska","year":"2010","journal-title":"HIV medicine"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"SW Worm","year":"2010","journal-title":"The Journal of infectious diseases"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1097\/QAD.0b013e32830fe35e","article-title":"Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients","volume":"22","author":"J Lundgren","year":"2008","journal-title":"AIDS"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/ciq244","article-title":"No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001\/ALLRT","volume":"52","author":"HJ Ribaudo","year":"2011","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/QAD.0b013e32832e7140","article-title":"Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients","volume":"23","author":"PY Hsue","year":"2009","journal-title":"AIDS"},{"key":"ref54","first-page":"H2363","article-title":"Nucleoside reverse transcriptase inhibitors impair endothelium-dependent relaxation by increasing superoxide","volume":"283","author":"RL Sutliff","year":"2002","journal-title":"American Journal of Physiology: Heart and Circulatory Physiology"},{"key":"ref55","unstructured":"Hansen L, Kennedy I, Sutliff R, Platt M, Gleason R (In Preparation) AZT induces intima-medial thickening, endothelial dysfunction, and arterial stiffening in mice."},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"WM El-Sadr","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.atherosclerosis.2008.10.012","article-title":"Human immunodeficiency virus per se exerts atherogenic effects","volume":"204","author":"U Oliviero","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/QAD.0b013e32832b514b","article-title":"Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis","volume":"23","author":"PY Hsue","year":"2009","journal-title":"AIDS"},{"key":"ref59","first-page":"261","article-title":"Arteriopathy in children with acquired immune deficiency syndrome","volume":"7","author":"VV Joshi","year":"1987","journal-title":"Pediatr Pathol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10024-003-1001-9","article-title":"Cardiac, aortic, and pulmonary arteriopathy in HIV-infected children: the Prospective P2C2 HIV Multicenter Study","volume":"7","author":"AR Perez-Atayde","year":"2004","journal-title":"Pediatric and developmental pathology: the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0923-2516(06)80033-6","article-title":"Coronary artery lesions and human immunodeficiency virus infection","volume":"144","author":"P Paton","year":"1993","journal-title":"Res Virol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0090-3019(96)00030-4","article-title":"Cerebral aneurysm in the HIV patient: a report of six cases","volume":"46","author":"AH Maniker","year":"1996","journal-title":"Surg Neurol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/clc.4960280311","article-title":"Viral load of the human immunodeficiency virus could be an independent risk factor for endothelial dysfunction","volume":"28","author":"A Blum","year":"2005","journal-title":"Clin Cardiol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00002030-200404300-00012","article-title":"Arterial stiffness and endothelial dysfunction in HIV-infected children","volume":"18","author":"D Bonnet","year":"2004","journal-title":"AIDS"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Lorenz MW, Stephan C, Harmjanz A, Staszewski S, Buehler A, et al. (2007) Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis.","DOI":"10.1016\/j.atherosclerosis.2006.12.022"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/QAI.0b013e31815e7453","article-title":"Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda","volume":"47","author":"K Buchacz","year":"2008","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Charakida M, Donald A, Green H, Storry C (2005) Early structural and functional changes of the vasculature in HIV-infected children. Circulation.","DOI":"10.1161\/CIRCULATIONAHA.104.517144"},{"key":"ref68","first-page":"49","article-title":"Dyslipidemia related to antiretroviral therapy","volume":"13","author":"V Estrada","year":"2011","journal-title":"AIDS reviews"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1017\/S0954422411000138","article-title":"Nutrition and the HIV-associated lipodystrophy syndrome","volume":"25","author":"CR Loonam","year":"2012","journal-title":"Nutrition research reviews"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"PM Ridker","year":"2002","journal-title":"The New England journal of medicine"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1001\/archinte.165.21.2479","article-title":"Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study","volume":"165","author":"CM Ballantyne","year":"2005","journal-title":"Archives of Internal Medicine"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/hs1101.098151","article-title":"Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study","volume":"32","author":"NS Rost","year":"2001","journal-title":"Stroke; a journal of cerebral circulation"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.qai.0000159323.59250.83","article-title":"Increased cardiovascular disease risk indices in HIV-infected women","volume":"39","author":"SE Dolan","year":"2005","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2006.09.013","article-title":"The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients","volume":"195","author":"M Masia","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/QAI.0b013e318189a794","article-title":"Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy","volume":"49","author":"AC Ross","year":"2008","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1468-1293.2008.00661.x","article-title":"Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy","volume":"10","author":"U Kristoffersen","year":"2009","journal-title":"HIV Med"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.atherosclerosis.2008.12.025","article-title":"Increased carotid intima media thickness is associated with depletion of circulating myeloid dendritic cells in HIV-infected patients on suppressive antiretroviral treatment","volume":"204","author":"M Lichtner","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"J Neuhaus","year":"2010","journal-title":"The Journal of infectious diseases"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/QAI.0b013e3181e222c9","article-title":"Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1","volume":"55","author":"TL Miller","year":"2010","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1086\/649560","article-title":"High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection","volume":"201","author":"J Baker","year":"2010","journal-title":"Journal of Infectious Diseases"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/QAD.0b013e32832995fa","article-title":"HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial","volume":"23","author":"A Calmy","year":"2009","journal-title":"AIDS"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/ATVBAHA.107.149179","article-title":"Vascular adhesion molecules in atherosclerosis","volume":"27","author":"E Galkina","year":"2007","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/15419069509081285","article-title":"Elevated concentrations of circulating intercellular adhesion molecule 1 (ICAM-1) and of vascular cell adhesion molecule 1 (VCAM-1) in HIV-1 infection","volume":"3","author":"L Gattegno","year":"1995","journal-title":"Cell Adhesion and Communication"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/clim.2000.4865","article-title":"Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients","volume":"95","author":"CM Mastroianni","year":"2000","journal-title":"Clinical immunology (Orlando, Fla)"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.2174\/138161207783018635","article-title":"Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis","volume":"13","author":"G Matarese","year":"2007","journal-title":"Current Pharmaceutical Design"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11883-007-0025-4","article-title":"Adiponectin and cardiovascular inflammatory responses","volume":"9","author":"Y Takemura","year":"2007","journal-title":"Current atherosclerosis reports"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/135965350400900206","article-title":"Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations","volume":"9","author":"ML Gougeon","year":"2004","journal-title":"Antiviral therapy"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0117125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T05:16:19Z","timestamp":1651814179000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0117125"}},"subtitle":[],"editor":[{"given":"Mario A.","family":"Ostrowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,27]]},"references-count":87,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0117125","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,27]]}}}